X

Organigram Selected For PAX Era Vaporizer Partnership

As licensed producers look for new options beyond pre-rolled dried flower products to provide for a consumer base seeking diversity, Organigram Holdings Inc. (NASDAQ: OGI, TSX-V: OGI) just landed a lucrative partnership with PAX Labs. 

Organigram is now one of only four cannabis companies selected to offer products compatible with the PAX Era oil vaporizer. 

The other selected partners from across the Canadian licensed industry included Aphria (TSX: APHA; NYSE: APHA), Aurora (NYSE: ACB; TSX: ACB), and The Supreme Cannabis Company (TSX: FIRE; OTCQX: SPRWF). 

Under the terms of the partnership, Organigram will fill PAX Era compatible pods at the company’s Moncton facility. Those vaporizer oil pods will be branded with Organigram’s Edison Cannabis Company label and shipped to all 10 of the company’s existing provincial retailer partners. 

Discussing the need for newer, industry-disrupting offerings that take advantage of tech advances, Organigram’s Chief Executive Officer Greg Engel commented: 

Cannabis 2.0 – the next generation of legal, adult use cannabis products – represents a world of opportunity. Innovative partnerships with exceptional companies like PAX mean our own product offering grows and our customers have access to cutting-edge technology and cannabis experiences.
 

Subscribe Now
Sign up to get Grizzle's latest news and analysis in your inbox!

Sending Message...


Organigram is already shipping Edison oil products in other formulations to partners around the country, which are produced through extraction deals previously struck with Valens GroWorks and 1812 Hemp. 

Seeking even more options beyond dried flower and oil products, the company also recently announced a major investment into upgrading a production facility to include an automated chocolate assembly line 

Expected to go into full operation later this year, that upgraded facility will produce cannabis-infused chocolate products after edible cannabis regulations are officially handed down from Health Canada in late 2019. 

In other Organigram news, earlier this week the company announced that a $115 million term loan and $25 million revolving credit facility were secured through the Bank of Montreal, which will mature in mid-2022. 

Those newly secured funds will go towards continued expansion as the company completes phases 4 and 5 of current facility upgrade projects at the Moncton campus. That site is projected to hit a production capacity of 113,000 kg of dried flower and other product types by the end of the year. 

The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Grizzle hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.

Subscribe Now
Sign up to get Grizzle's latest news and analysis in your inbox!

Sending Message...


Categories: Marijuana News
Ty Arthur: Ty Arthur has spent the last decade of his journalism career covering everything from cutting-edge tech to local news through outlets such as the Houston Chronicle. He has focused on the counterculture aspects of society, from marijuana legalization to underground music through Metalunderground.com and rapidly changing trends in the entertainment industry. He lives in the cold, dark north with his wife and son.
Related Post
Disqus Comments Loading...